China NT Pharma Group manufactures, sales and distributes pharmaceutical and vaccine products and provides marketing and promotion services to. Co.'s segments include: third-party pharmaceutical promotion and sales, which is engaged in the pharmaceutical promotion and sales derives turnover from selling and providing marketing and promotion services; proprietary products production and sales, which is engaged in the NT branded products production and sales derives turnover from production and sales of NT branded products and generic drugs; and third-party vaccines and other pharmaceuticals, which includes sales from vaccine promotion, vaccine supply chain and pharmaceutical supply chain.
Research suggests that directors know their companies better than the market. For many investors it is intuitive that following the trading patterns of directors and other company insiders can lead to successful investing. They often have detailed knowledge about their companies and generally know when the shares are incorrectly valued. However, that is not always true and with large numbers of trades reported every day on exchanges around the world, it is difficult to know which to follow.
SmartInsider provides valuable insight by supplementing and analysing reported transactions to achieve real insight with a focus on identifying the ‘Smart Insiders’ and highlighting the stand-out transactions they make. Our proven track-record and thirty year pedigree are backed by more recent statistical analysis of historical data.
Our service offers director dealing reports, company reports and monthly summaries with a fully interactive website for further research. We can also provide quant feeds and customised alerts to suit every need at the frequency preferred. SmartInsider covers all markets with a regulatory requirement to report insider activity, over 60,000 companies across 55 markets.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.